Trinity Biotech plc (TRIB: Quote) Monday reported fourth-quarter profit of $4.0 million or 18.4 cents per american depositary receipt, or ADR, rising from last year's $3.7 million or 16.6 cents per ADR.
Revenues for the quarter rose 4 percent to $20.0 million from $19.2 million last year due to higher HIV sales in Africa and USA. Point-of-care revenue increased 12.4 percent while clinical laboratory revenue rose 2.1 percent from last year.
Click here to receive FREE breaking news email alerts for Trinity Biotech plc and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org